Provia Laboratories, a bio banking project of market research & private equity company Grace Century, has reported 47 per cent quarterly growth in enrolments for its Store-a-tooth cryogenic storage service of dental stem cells.

This is the highest-ever recorded growth rate in enrolments for the pioneering technology, which enables stem cell to be stored for future therapeutic use, a statement said.

Store-a-tooth technology enables dental stem cells to be stored and used in future years to take advantage of future stem cell-therapies being researched for conditions such as cardiovascular disorders, type 1 diabetes and muscular dystrophy.

The impressive results are attributed to a dramatic increase in the awareness and interest of the potential benefits of Store-a-tooth technology, seen during 2015. In particular, a markedly enhanced level of online activity and research on Store-a-tooth has significantly boosted enrolments. In addition, continued International expansion and improved marketing tools within partner dental offices have contributed to the recent growth. Multiple markets are expanding, further validating Provia’s  original business model.

Grace Century's CEO, Scott Wolf, said: "With Provia’s consistent success, we are clearly seeing the future in the field of stem cell storage technology. Recent capital commitments and advancing negotiations with institutional sources give us confidence in a bright future for Store-a-tooth technology and we are tentatively predicting further double or even triple-digit growth for 2016."

Howard Greenman, CEO of Provia said: "Our recent performance is a testament to the commitment of our team and the company's vision. We are proud to continue developing our current network of healthcare providers who help raise awareness of our technology in their communities. This network is the building block for building awareness of our important technology." – TradeArabia News Service